XML 32 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes
7.
INCOME TAXES

The components of pretax (loss) income attributable to domestic and foreign operations are as follows (in thousands):

 

Year Ended December 31,

 

 

2023

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

$

(80,486

)

 

$

54,799

 

 

$

(261,900

)

 

Foreign

 

 

(4,061

)

 

 

(4,937

)

 

 

(13,019

)

 

Pretax (loss) income

 

$

(84,547

)

 

$

49,862

 

 

$

(274,919

)

 

The goodwill and intangible asset impairment charges (see Note 12) recognized during the year ended December 31, 2023 are included in the domestic pretax loss in the table above.

The Company's income tax provision (benefit) consisted of the following (in thousands):

 

Year Ended December 31,

 

 

2023

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

Current provision:

 

 

 

 

 

 

 

 

 

 

Federal

 

$

41,804

 

 

$

37,470

 

 

$

15,263

 

 

State

 

 

10,053

 

 

 

8,387

 

 

 

5,620

 

 

Total current provision

 

 

51,857

 

 

 

45,857

 

 

 

20,883

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred provision (benefit):

 

 

 

 

 

 

 

 

 

 

Federal

 

 

(36,253

)

 

 

(26,570

)

 

 

(35,284

)

 

State

 

 

(10,080

)

 

 

(7,831

)

 

 

(11,599

)

 

Foreign

 

 

(502

)

 

 

1,054

 

 

 

(2,080

)

 

Change in valuation allowance

 

 

502

 

 

 

(1,054

)

 

 

2,080

 

 

Total deferred benefit

 

 

(46,333

)

 

 

(34,401

)

 

 

(46,883

)

 

Total income tax provision (benefit)

 

$

5,524

 

 

$

11,456

 

 

$

(26,000

)

 

 

The Company’s effective income tax rate differs from the federal statutory rate as follows (in thousands, except percentages):

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Federal income tax benefit at statutory rate

$

(17,755

)

 

 

21.0

 %

 

$

10,471

 

 

 

21.0

 %

 

$

(57,733

)

 

 

21.0

 %

Goodwill impairment

 

16,255

 

 

 

(19.2

)

 

 

 

 

 

 

 

 

 

 

 

 

Executive compensation

 

12,555

 

 

 

(14.8

)

 

 

12,508

 

 

 

25.0

 

 

 

25,362

 

 

 

(9.2

)

Fair value of warrants

 

3,170

 

 

 

(3.7

)

 

 

(5,475

)

 

 

(11.0

)

 

 

13,545

 

 

 

(4.9

)

Stock-based compensation

 

(3,844

)

 

 

4.5

 

 

 

(4,074

)

 

 

(8.1

)

 

 

(3,647

)

 

 

1.3

 

Research and experimentation credit

 

(6,920

)

 

 

8.2

 

 

 

(3,510

)

 

 

(7.0

)

 

 

(2,914

)

 

 

1.1

 

Impact of foreign operations

 

1,794

 

 

 

(2.1

)

 

 

2,807

 

 

 

5.6

 

 

 

261

 

 

 

(0.1

)

Valuation allowance

 

502

 

 

 

(0.6

)

 

 

(1,054

)

 

 

(2.1

)

 

 

2,080

 

 

 

(0.8

)

State and local taxes-net of federal income tax effect

 

(22

)

 

 

0.0

 

 

 

439

 

 

 

0.9

 

 

 

(4,723

)

 

 

1.7

 

Other nondeductible expenses

 

836

 

 

 

(1.0

)

 

 

344

 

 

 

0.7

 

 

 

756

 

 

 

(0.3

)

Uncertain tax positions

 

396

 

 

 

(0.5

)

 

 

(303

)

 

 

(0.6

)

 

 

594

 

 

 

(0.2

)

Foreign rate difference

 

(164

)

 

 

0.2

 

 

 

(182

)

 

 

(0.4

)

 

 

(493

)

 

 

0.2

 

Other—net

 

(1,279

)

 

 

1.5

 

 

 

(515

)

 

 

(1.0

)

 

 

912

 

 

 

(0.3

)

Income tax provision (benefit)

$

5,524

 

 

 

(6.5

)%

 

$

11,456

 

 

 

23.0

 %

 

$

(26,000

)

 

 

9.5

 %

The Company made income tax payments of $43.0 million, $55.7 million and $15.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. The Company received insignificant refunds from the Internal Revenue Service and various states during the years ended December 31, 2023, 2022 and 2021, respectively.

The approximate income tax effect of each type of temporary difference giving rise to deferred income tax assets and liabilities as of December 31, 2023 and 2022 was as follows (in thousands):

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

Deferred income tax assets:

 

 

 

 

 

Stock-based compensation

$

36,329

 

 

$

37,156

 

Operating lease liabilities

 

13,751

 

 

 

14,339

 

Accrued compensation

 

10,373

 

 

 

10,962

 

Net operating losses—foreign

 

10,875

 

 

 

10,373

 

Capitalized R&E—net of amortization

 

26,082

 

 

 

10,221

 

Sales allowances and doubtful accounts

 

1,393

 

 

 

1,339

 

Interest expense limitation

 

 

 

 

673

 

Net operating losses—domestic (state)

 

479

 

 

 

506

 

Research and experimental credit

 

373

 

 

 

386

 

Other

 

775

 

 

 

826

 

Total deferred income tax assets

 

100,430

 

 

 

86,781

 

Valuation allowance for deferred tax asset

 

(10,875

)

 

 

(10,373

)

Net deferred income tax assets

 

89,555

 

 

 

76,408

 

Deferred income tax liabilities:

 

 

 

 

 

Intangible asset amortization

 

255,572

 

 

 

282,032

 

Software, equipment and property depreciation and amortization

 

11,541

 

 

 

17,628

 

Deferred contract costs

 

10,044

 

 

 

9,235

 

Operating lease assets

 

7,078

 

 

 

7,604

 

Interest rate cap

 

685

 

 

 

1,607

 

Total deferred income tax liabilities

 

284,920

 

 

 

318,106

 

Net deferred income tax liabilities

$

195,365

 

 

$

241,698

 

Valuation Allowance—The Company has accumulated net operating losses related to its foreign subsidiaries of $10.9 million and $10.4 million at December 31, 2023 and 2022, respectively. A valuation allowance equal to 100% of the related tax benefit has been established as of December 31, 2023 and 2022. The valuation allowance increased $0.5 million during the year ended December 31, 2023, decreased $1.0 million during the year ended December 31, 2022 and increased $2.0 million during the year ended December 31, 2021. The changes in the valuation allowance during each year were due to foreign subsidiaries' net operating losses in the current year and the expiration of prior year's net operating losses. No amounts were released during the years ended December 31, 2023, 2022 and 2021. The net operating losses are set to expire in 2024 through 2028 as China allows for a five-year carryforward.

The state net operating losses at December 31, 2023 of $0.5 million are expected to be more likely than not fully utilized. Most states allow for a 20-year carryforward of net operating losses. All losses will expire in 2035-2042 if not fully utilized.

The change in unrecognized tax benefits excluding interest and penalties for the years ended December 31, 2023 and 2022 was as follows (in thousands):

 

 

2023

 

 

2022

 

Balance at beginning of year

$

3,723

 

 

$

3,722

 

Additions based on tax positions related to the current year

 

1,062

 

 

 

797

 

Additions based on adjustments to tax positions related to prior years

 

527

 

 

 

105

 

Reductions for tax positions of prior years

 

(897

)

 

 

(901

)

Balance at end of year

$

4,415

 

 

$

3,723

 

The Company believes its liability for unrecognized tax benefits, excluding interest and penalties, will not significantly change over the following twelve months. However, due to the open statute of limitations within the various jurisdictions in which the Company files tax returns, the amount of any change cannot be reasonably estimated and it is possible there could be significant changes in the amount of unrecognized tax benefits over the following twelve months.

The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. As of December 31, 2023 and 2022, the amount accrued for interest and penalties was not material. The Company reflects its liability for unrecognized tax benefits within income taxes payable and other liabilities in its consolidated balance sheets. The amounts included in “reductions for tax positions of prior years” represent expirations of statutes of limitation and decreases in the unrecognized tax benefits relating to settlements reached with taxing authorities during each year shown.

With few US State exceptions, the major jurisdictions subject to examination by the relevant taxing authorities and open tax years, stated as the Company’s fiscal years, are as follows:

 

Jurisdiction

 

Open Tax Years

US Federal

 

2020 - 2022

US States

 

2020 - 2022

China

 

2020 - 2022

Canada

 

2020 - 2022